Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-04-26
2011-04-26
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S292000
Reexamination Certificate
active
07932262
ABSTRACT:
The invention provides quinazoline compounds that are inhibitors of PDK1. Also provided are pharmaceutical compositions including the compounds, and methods of treating proliferative diseases, such as cancers, with the compounds or compositions.
REFERENCES:
patent: 4169846 (1979-10-01), Kidani et al.
patent: 4323581 (1982-04-01), Gander
patent: 4689338 (1987-08-01), Gerster
patent: 4929624 (1990-05-01), Gerster et al.
patent: 5041424 (1991-08-01), Saulnier et al.
patent: 5238944 (1993-08-01), Wick et al.
patent: 5266575 (1993-11-01), Gerster et al.
patent: 5268376 (1993-12-01), Gester
patent: 5346905 (1994-09-01), Gerster
patent: 5352784 (1994-10-01), Nikolaides et al.
patent: 5389640 (1995-02-01), Gerster et al.
patent: 5395937 (1995-03-01), Nikolaides et al.
patent: 5457105 (1995-10-01), Barker
patent: 5478932 (1995-12-01), Rinehart et al.
patent: 5482936 (1996-01-01), Lindstrom
patent: 5494916 (1996-02-01), Lindstrom et al.
patent: 5525613 (1996-06-01), Wynn et al.
patent: 5616582 (1997-04-01), Barker
patent: 5621100 (1997-04-01), Lewis et al.
patent: 5747498 (1998-05-01), Schnur et al.
patent: 5770599 (1998-06-01), Gibson
patent: 5780454 (1998-07-01), Adams et al.
patent: 5883113 (1999-03-01), Tang et al.
patent: 6025387 (2000-02-01), Yoo et al.
patent: 6083505 (2000-07-01), Miller et al.
patent: 6258812 (2001-07-01), Bold et al.
patent: 6331555 (2001-12-01), Hirth et al.
patent: 0134846 (2003-07-01), Windsor et al.
patent: 6605617 (2003-08-01), Renhowe et al.
patent: 0171303 (2003-09-01), Gallop et al.
patent: 0073044 (2004-04-01), Sharma et al.
patent: 6727256 (2004-04-01), Carter et al.
patent: 6774237 (2004-08-01), Renhowe et al.
patent: 6982260 (2006-01-01), Barvian et al.
patent: WO-88/07045 (1988-09-01), None
patent: WO-89/07105 (1989-08-01), None
patent: WO-93/07153 (1993-04-01), None
patent: WO-93/08809 (1993-05-01), None
patent: WO-94/05304 (1994-03-01), None
patent: WO-94/06799 (1994-03-01), None
patent: WO-94/10202 (1994-05-01), None
patent: WO-95/12660 (1995-05-01), None
patent: WO-95/17182 (1995-06-01), None
patent: WO-96/06116 (1996-02-01), None
patent: WO-96/13506 (1996-05-01), None
patent: WO-96/30347 (1996-10-01), None
patent: WO-97/07081 (1997-02-01), None
patent: WO-97/20842 (1997-06-01), None
patent: WO-97/21701 (1997-06-01), None
patent: WO-97/29780 (1997-08-01), None
patent: WO-98/04541 (1998-02-01), None
patent: WO-98/05769 (1998-02-01), None
patent: WO-98/43095 (1998-10-01), None
patent: WO-99/02162 (1999-01-01), None
patent: WO-99/61422 (1999-12-01), None
patent: WO-00/27422 (2000-05-01), None
patent: WO-01/00245 (2001-01-01), None
patent: WO-01/04125 (2001-01-01), None
patent: WO-01/32651 (2001-05-01), None
patent: WO-01/38315 (2001-05-01), None
patent: WO-01/60814 (2001-08-01), None
patent: WO-01/79255 (2001-10-01), None
patent: WO-02/02552 (2002-01-01), None
patent: WO-02/30941 (2002-04-01), None
patent: WO-02/057423 (2002-07-01), None
patent: WO-02/062826 (2002-08-01), None
patent: WO-03/004505 (2003-01-01), None
patent: WO-03/024978 (2003-03-01), None
patent: WO-03/064397 (2003-08-01), None
patent: WO-03/082272 (2003-10-01), None
patent: WO-2004/006834 (2004-01-01), None
patent: WO-2004/009769 (2004-01-01), None
patent: WO-2004/060308 (2004-07-01), None
patent: WO-2004/064759 (2004-08-01), None
patent: WO-2004/065378 (2004-08-01), None
patent: WO-2004/087153 (2004-10-01), None
patent: WO-2005/030776 (2005-04-01), None
patent: WO-2006/031878 (2006-03-01), None
patent: WO-2006/118256 (2006-11-01), None
patent: WO 2006/137421 (2006-12-01), None
patent: WO-2007/084786 (2007-07-01), None
International Preliminary Report on Patentability for PCT/US2007/008592, issued on Oct. 8, 2008, 9 pages.
International Search Report for PCT/US2007/008592, mailed on Sep. 27, 2007, 4 pages.
Lee, “Diffusion-Controlled Matrix Systems” pp. 155-198 in Treatise on Controlled Drug Delivery (1992), Kydonieus, ed., Marcel Dekker, Inc., New York.
Parsons et al., Nature (2005) 436:792.
Prescott, ed., Methods in Cell Biology, vol. XIV (1976), Academic Press, New York, p. 33.
Ron and Langer, “Erodible Systems” pp. 199-224 in Treatise on Controlled Drug Delivery (1992), Kydonieus, ed., Marcel Dekker, Inc., New York.
Office Action for San Marino Patent Application No. SM-AP-200800059, mailed on Feb. 23, 2009, 2 pages [English translation included].
Aikawa Mina
Amiri Payman
Basham Stephen E.
Dove Jeffrey
Jain Rama
Kathardekar Vinit
McDowell Brian
Novartis AG
Wilson James O
LandOfFree
Quinazolines for PDK1 inhibition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinazolines for PDK1 inhibition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinazolines for PDK1 inhibition will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2670976